SYMBOLLON CORP
SC 13E4, 1996-12-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CHARTWELL RE CORP, S-8, 1996-12-13
Next: FIDELITY BANCORP INC /DE/, DEF 14A, 1996-12-13



                                
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                          Issuer Tender Offer Statement
      (Pursuant to Section 13(e)(1) of the Securities Exchange Act of 1934)

                                (Amendment No. )

                              SYMBOLLON CORPORATION
 ................................................................................
                                (Name of Issuer)

                              SYMBOLLON CORPORATION
 ................................................................................
                      (Name of Person(s) Filing Statement)

                              Class B Common Stock
 ................................................................................
                         (Title of Class of Securities)

                                      None
 ................................................................................
                      (CUSIP Number of Class of Securities)

                                Paul C. Desjourdy
                              Symbollon Corporation
                              122 Boston Post Road
                          Sudbury, Massachusetts 01776
                                 (508) 443-0165
 ................................................................................
   (Name, Address and Telephone Number of Person Authorized to Receive Notices
        and Communications on Behalf of the Person(s) Filing Statements)

                                December 13, 1996
 ................................................................................
     (Date Tender Offer First Published, Sent or Given to Security Holders)

Calculation of Filing Fee
       Transaction Valuation[1]                    Amount of filing fee
       $1,271,042.19                               $254.21
        .......................                    ....................
[1] Transaction Valuation based on average of the bid and asked price of Class A
Common Stock on December 11, 1996 multiplied by the number of outstanding shares
of Class B Common Stock (1,196,275).

 ....  Check box if any part of the fee is offset as provided by Rule 0-11(a)(2)
and identify the filing with which the offsetting fee was previously paid.
Identify the previous filing by registration statement number, or the Form or
Schedule and the date of its filing.
Amount Previously Paid:  .................
Form or Registration No.:  ...............
Filing Party:  ...........................
Date Filed:  .............................

                               Page 1 of 5 Pages

<PAGE>


Item 1.           Security and Issuer.
                  -------------------

         (a) The name of the issuer is Symbollon Corporation  (hereinafter,  the
         "Company").  The Company's  principal  executive offices are located at
         122 Boston Post Road, Sudbury, Massachusetts 01776.

         (b) This statement  relates to shares of the Class B Common Stock,  par
         value  $.001  per  share  ("Class  B Common  Stock"),  each of which is
         convertible  at the  option  of the  holder  into one  share of Class A
         Common Stock,  par value $.001 per share ("Class A Common  Stock"),  of
         the Company.  As of December 11, 1996,  there were 1,196,275  shares of
         Class B Common Stock  outstanding.  The Company is requesting that each
         holder of the Class B Common  Stock  voluntarily  convert  all of their
         shares of Class B Common Stock into Class A Common Stock (the  "Company
         Request"). No additional consideration is offered. Conversion elections
         submitted pursuant to the Company Request will be effected if (but only
         if) on or prior to  January  15,  1997 at least 98% of the  outstanding
         shares of the Class B Common Stock elect to convert  their  shares.  If
         the conversions are not effected  pursuant to the Company Request,  the
         Class B Common  Stockholders  retain the right to  thereafter  elect to
         convert their shares. Officers, directors and affiliates of the Company
         hold the  following  number  of shares  of Class B Common  Stocks:  Dr.
         Kessler,  412,458 shares;  Dr. Richards,  357,343 shares; Mr. Rosenthal
         (through indirect ownership in Magar, Inc.), 272,372 shares; Mr. Paley,
         42,873 shares; and Magar, Inc., 272,372.

         (c) There is no  established  public  trading  market for the Company's
         Class B Common Stock.  The Company's Class A Common Stock trades on the
         NASDAQ  Small Cap Market under the symbol  SYMBA.  The  following  sets
         forth the high and low bid prices for each quarterly  period during the
         past two years, as reported by NASDAQ.

                                 Fiscal 1996 (1)              Fiscal 1995 (1)  
                               ------------------           ------------------ 
                               High(2)    Low (2)           High(2)    Low (2)
                               -------    -------           -------    -------

         First quarter          6 1/2      4 1/8             6 1/8      3 3/4
         Second quarter         6 3/8      1 5/8             8 1/4      4 7/8
         Third quarter          1 3/4        3/4             8 3/4      1 3/4
         Fourth quarter(3)      2 1/2        5/8             4 1/2      1 7/8
- --------------------------
         (1)  The Company's fiscal year ends December 31.

         (2) Quotations  reflect  inter-dealer  prices  without retail  mark-up,
         mark-down or commission, and may not represent actual transactions.

         (3)  The fourth quarter of 1996 reflects the high and low bid prices
         from October 1, 1996 to December 11, 1996.

         (d)      This statement is being filed by the Company.

                               Page 2 of 5 Pages

<PAGE>


Item 2.           Source and Amount of Funds or Other Consideration.
                  -------------------------------------------------

         (a) The sole consideration for the Class B Common Stock to be converted
         will be Class A Common Stock from the Company's authorized but unissued
         reserve.  The exchange will be  one-for-one,  so a maximum of 1,196,275
         shares of Class A Common Stock will be issued.

         (b)      N/A.

Item 3.           Purpose of the Tender Offer and Plans or Proposals of the 
                  ---------------------------------------------------------
                  Issuer or Affiliate.
                  -------------------

         The  purpose of the  Company  Request is to  eliminate  the dual voting
         structure of the Company's  outstanding equity  securities.  Presently,
         the Class B Common  Stock have five  votes per  share,  and the Class A
         Common Stock and the Series A Preferred  Stock have one vote per share.
         If all Class B Common  Stockholders  convert into Class A Common Stock,
         then all remaining outstanding voting securities will have equal voting
         privileges  (one vote per share).  Any Class B Common  Stock  converted
         will,  from and  after  the date of  conversion,  have  the  status  of
         authorized and unissued shares of Class B Common Stock.

         Conversion  of the  Class B  Common  Stock  would  have the  effect  of
         substantially  reducing  the voting  control of the Company held by the
         current  members  of the  Board of  Directors,  who own or  control  an
         aggregate of  1,085,046  shares (or 90.7%) of the  outstanding  Class B
         Common Stock, representing 70.3% of the total votes eligible to be cast
         by  stockholders.  Each member of the Board of Directors  has indicated
         his intention to convert his shares of Class B Common Stock pursuant to
         the  Company  Request.  If all  shares  of  Class B  Common  Stock  are
         converted, members of the Board of Directors would own or control 40.2%
         of the total votes eligible to be cast by stockholders.

         Except  as set  forth  in this  Item 3, the  Company  does not have any
         present  plans or proposals  that relate to or that would result in any
         of the  actions  specified  in clauses (a) through (j) of Item 3 of the
         Schedule 13E-4.

Item 4.           Interest in Securities of the Issuer.
                  ------------------------------------

         There were no  transactions in the Class B Common Stock effected during
         the past 40  business  days by the  Company or any  executive  officer,
         director or control person.  One of the Company's  executive  officers,
         Paul C. Desjourdy,  purchased  39,700 shares of Class A Common Stock in
         open market  transactions  from November 8 through November 20, 1996 at
         prices ranging from $.72 to $1.44 per share.

                               Page 3 of 5 Pages

<PAGE>


Item 5            Contracts, Arrangements, Understandings or Relationships with 
                  -------------------------------------------------------------
                  Respect to the Issuer's Securities.
                  ----------------------------------

         Except  as set  forth  in Item 3 above,  neither  the  Company  nor any
         director, executive officer or control person thereof has any contract,
         arrangement,  understanding  or relationship  (legal or otherwise) with
         any person with respect to any  securities  of the Company,  including,
         but not limited to, transfer or voting of any such securities, finder's
         fees,  joint  ventures,  loan or options  arrangements,  puts or calls,
         guarantees of profits,  division of profits or losses, or the giving or
         withholding of proxies.

Item 6.           Persons Retained, Employed or to Be Compensated.
                  -----------------------------------------------

         The Company has not employed,  retained or compensated any person,  nor
         will   any   person   be   compensated,   to  make   solicitations   or
         recommendations in connection with the Company Request.  In addition to
         the Company's preparation and mailing of the Company Request materials,
         directors,  officers  and other  employees  of the  Company may solicit
         conversions pursuant to the Company Request by telephone or other means
         of communication.

Item 7.           Financial Information.
                  ---------------------

         The Company  incorporates  herein by  reference  the audited  financial
         statements  for the past two  years  contained  in the  Company's  Form
         10-KSB for the year ended  December  31,  1995 under Item 5 - Financial
         Statements,   and  the  unaudited   balance   sheets  and   comparative
         year-to-date income statements and statements of cash flows and related
         earnings  per share  amounts  required to be included in the  Company's
         most recent quarterly report contained in the Company's Form 10-QSB for
         the  quarter  ended  September  30,  1996  under  Item  1  -  Financial
         Statements.

Item 8.           Additional Information.
                  ----------------------

         None.

                               Page 4 of 5 Pages

<PAGE>


Item 9.           Material to be Filed as Exhibits.
                  --------------------------------

         (a)      Letter  dated  December  13,  1996  to  each  Class  B  Common
                  Stockholder requesting voluntary conversion of their holdings,
                  together with Conversion  Instructions,  Notice of Election to
                  Convert  Form  and  Lost  Stock   Certificate   Affidavit  and
                  Indemnity Agreement;

                  The Company's Form 10-KSB for the year ended December 31, 1995
                  (previously filed and incorporated by reference.);

                  The Company's Form 10-QSB for the quarter ended  September 30,
                  1996 (previously filed and incorporated by reference.);

                  Press Release  regarding the 510(k)  Withdrawal dated December
                  10, 1996.

                  Press Release regarding the Company Request dated December 13,
                  1996.


                                    SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the
information set forth in this statement is true, complete and correct.

Date:    December 13, 1996

                                    SYMBOLLON CORPORATION

                                    /S/ Paul C. Desjourdy
                                    -------------------------------------------
                                    Paul C. Desjourdy, Executive Vice President
                                    and authorized signatory

                               Page 5 of 5 Pages


December 13, 1996

[Name of Class B Stockholder]
[Address]
[City, State/Province Zip/Postal Code]

         Re:      Request to Convert Class B Common Stock
                  ---------------------------------------

Dear [Recipient]:

As a Class B Common Stockholder, you have been aware that the Company's publicly
traded Class A Common Stock has suffered a  significant  decrease in value.  The
Board of Directors  believes  that by  converting  the Class B Common Stock into
publicly  traded shares of Class A Common  Stock,  and thereby  eliminating  the
supervoting  rights  attendant  to the Class B, that the Company  should have an
increased  opportunity to broaden the attractiveness and exposure of the Company
in the investment  community.  In order to accomplish  this important  goal, the
Company is requesting the Class B Common  Stockholders  to  voluntarily  convert
their  outstanding  shares of the Class B Common  Stock into an equal  number of
Class A. Members of the Board of Directors who in the aggregate own, or control,
90.7% of the  outstanding  shares of Class B Common Stock have  indicated  their
intention to convert their shares (and cause the conversion of their  controlled
shares) as part of this request.

As of December 11,  1996,  there were  1,196,275  shares of Class B Common Stock
outstanding,  1,287,137  shares of Class A Common  Stock and  444,444  shares of
Series A Preferred  Stock.  These Class B shares  represented  5,981,375  of the
total 7,712,956 (or 77.6%) votes eligible to be cast by stockholders. Members of
the Board of Directors own, or control,  1,085,046 (or 90.7%) of the outstanding
Class B Common Stock,  representing 70.3% of the total votes eligible to be cast
by  stockholders.  If all of the Class B Common Stock is  converted  pursuant to
this  request,  members of the Board of Directors  would own or control 40.2% of
the total votes eligible to be cast by stockholders.  Accordingly, by converting
the Class B Common Stock, voting control of the Company will be shifted from the
Board of Directors to the shareholders as a whole.


<PAGE>

In accordance with the enclosed instructions,  the Company requests each Class B
Common  Stockholder  to  voluntary  convert  his or her  holdings by signing the
attached  notice of election to convert and  returning  it,  together  with such
holder's  Class B  Common  Stock  certificates  to the  undersigned  care of the
Company.  Any rights or restrictions  presently  existing regarding your Class B
Common  Stock  will  remain  in place  for the  shares  of Class A Common  Stock
received by you upon conversion. Accordingly, any shares of Class B Common Stock
subject to the Stock  Restriction  Agreement  will  remain  subject to the Stock
Restriction Agreement upon conversion into Class A Common Stock. Therefore, each
Class B holder will receive two Class A certificates,  one  representing  shares
eligible for resale and one representing shares subject to the Stock Restriction
Agreement.  Unless a Stockholder advises the Company otherwise, all certificates
will be mailed to the Stockholder at his or her address set forth above.

Stockholders  will have until  January 15, 1997 to return their signed notice of
election to convert. Until said date, holders who have submitted their notice of
election and shares may withdraw them by written notice  received by the Company
on or prior to said date.  As provided in the notice of election to convert,  if
at least 98% of the  outstanding  shares of Class B Common Stock have elected to
be converted,  the Company will complete the conversions pursuant to the Company
Request.  If less than 98% of the shares elect to be  converted  pursuant to the
Company  Request,  then  the  Company  will  return  the  Class B  Common  Stock
certificates submitted by a stockholder to each such stockholder. If the Class B
Common Stock is returned because of the failure to obtain such 98% election, the
stockholders  retain the right to  thereafter  elect to convert  their shares of
Class B Common Stock.

Please feel free to call Paul C.  Desjourdy at (508)  443-0165,  if you have any
questions  or  concerns  regarding  the  above.  Thank  you for  your  time  and
consideration.

Sincerely,




Paul C. Desjourdy
Executive Vice President/CFO

Enclosure:  Schedule 13E-4, with the 1995 Form 10-KSB and the latest Form 10-QSB
            Instructions to Complete Conversion
            Notice of Election to Convert Form
            Lost Stock Certificate Affidavit and Indemnity Agreement
            Press Release regarding 510(k) Withdrawal dated December 10, 1996
            Press Release regarding the Company Request dated December 13, 1996



<PAGE>


                                  INSTRUCTIONS
                                       TO
                               COMPLETE CONVERSION



1.    Read the Schedule 13E-4 enclosed regarding the Company's request for
      conversion.

2.    Sign the Notice of Election to Convert Form.

3.    Locate your Class B Common Stock Certificate(s).  Your stock certificate
      number(s) are ___________.  If you can not find your stock certificate(s),
      then complete the Lost Stock Certificate Affidavit and Indemnity Agreement
      enclosed.

4.   Return to  Symbollon  in the  envelope  provided  (1) the signed  Notice of
     Election to Convert Form, (2) your Class B Common Stock Certificate(s), and
     (3)  if  applicable,  the  signed  Lost  Stock  Certificate  Affidavit  and
     Indemnity Agreement.


                 YOUR PROMPT ATTENTION TO THIS MATTER IS GREATLY
                 APPRECIATED. THE COMPANY REQUEST FOR CONVERSION
                        WILL EXPIRE ON JANUARY 15, 1997.

If the 98% condition is satisfied,  promptly after the expiration of the Company
request period, Symbollon will send to you new Class A Common Stock certificates
replacing  your Class B Common Stock  certificates.  If the 98% condition is not
satisfied, Symbollon will return your Class B Common Stock certificates promptly
after the expiration date.

If you have any questions or concerns  regarding  this matter,  please  contract
Paul C. Desjourdy at (508) 443-0165.



<PAGE>


                          NOTICE OF ELECTION TO CONVERT
                 CLASS B COMMON STOCK INTO CLASS A COMMON STOCK


         The undersigned does hereby elect to convert the below indicated shares
of Class B Common Stock of Symbollon  Corporation into an equal number of shares
of Class A Common Stock of Symbollon  Corporation,  provided  that this election
will be of no further force and effect if, on or prior to January 15, 1997, less
than 98% of the  outstanding  shares  of Class B Common  Stock  shall  have duly
submitted  notices of election  to  convert.  I  understand  that any  transfer,
forfeiture and other restriction  affecting any Class B Common Stock will remain
applicable to the Class A Common Stock received upon conversion.

                  SYMBOLLON CORPORATION
                  CLASS B COMMON STOCK CERTIFICATE(S) NOS:  _____________
                  REPRESENTING COLLECTIVELY _______________ SHARES

         The undersigned  further  understands that such election may be revoked
any time before  January 15, 1997 by notifying  the Company in writing  prior to
such date.  On January 15, 1997,  so long as this Consent has not been  revoked,
the Company will process the conversion of the  undersigned's  shares of Class B
Common Stock into shares of Class A Common Stock provided at least 98% of all of
the  outstanding  shares of Class B Common  Stock have at that time elected such
conversion.  If less than 98% of the outstanding  shares of Class B Common Stock
shall have agreed to the transfer by the above  mentioned date, the Company will
return to you your Class B Common Stock certificates.

         Subject to  satisfaction  of the above  mentioned 98%  conversion,  the
undersigned  hereby  assigns  to  Symbollon  Corporation,  and  constitutes  and
appoints  Paul C.  Desjourdy  attorney  to  transfer  on the books of  Symbollon
Corporation,  the above  indicated  stock with full power of substitution in the
premises.

                             [Enter Social Security or Taxpayer Identification
                              Number: ______________________________]

                              IMPORTANT: The signature to this Consent must
                              correspond with the name(s) as written upon the
                              face of the certificate(s) in every particular
                              without alteration.



                              -----------------------------------------



                              -----------------------------------------



                              Date: ___________________________________

<PAGE>


            LOST STOCK CERTIFICATE AFFIDAVIT AND INDEMNITY AGREEMENT

         The undersigned, being first duly sworn, states that:

         1. The undersigned  makes this affidavit as the true,  lawful,  present
and sole  owner(s)  of Class B Common  Stock  Certificate(s)  Nos.  ____________
representing collectively _____________ shares (the "Certificates") of Symbollon
Corporation (the "Company").

         2. The  undersigned  believes  that the  Certificates  have been  lost,
stolen or destroyed  because the  undersigned  have  diligently  searched all of
his/her  financial  records and papers and the  Certificates  are no-where to be
found.

         3.  The  undersigned  further  state  that  the  Certificates  were not
endorsed,  have not been pledged, sold, delivered,  transferred or assigned. The
undersigned  agrees that in the event of the recovery of the Certificates at any
time after the issuance of new certificate(s) in place thereof,  the undersigned
will cause the Certificates to be returned to the Company for cancellation.

         4. The  undersigned  hereby request the Company to issue or cause to be
issued to the  undersigned new  certificate(s)  for an equal number of shares of
the Company's  Class A Common Stock pursuant to the executed  Notice of Election
to Convert Form enclosed herewith to replace the Certificates  without requiring
the surrender of the Certificates for cancellation.

         5. In  consideration  of the Company  complying with said request,  the
undersigned, his/her legal representatives, successors and assigns, hereby agree
to indemnify  and hold harmless the Company,  its  successors  and assigns,  and
their directors,  officers, agents or employees (collectively,  the "Obligees"),
and each of them,  from and  against  any and all  claims,  actions  and  suits,
whether  groundless or otherwise  and from and against any and all  liabilities,
losses,  damages,  costs,  charges,  counsel fees and other  expenses,  of every
nature and character, which the Obligees or any of them at any time shall or may
sustain or incur by reason of any claim or demand  which may be made as a result
of  the  issuance  of new  certificate(s)  in  place  of  the  Certificates  for
cancellation or by reason of any payment, transfer,  exchange or other act which
the  Obligees,  or any of them,  may do or cause to be done with  respect to the
Certificates whether or not such liabilities,  losses, costs,  damages,  counsel
fees  and  other   expenses  arise  or  occur  through   accident,   over-sight,
inadvertence or neglect on the part of the Obligees.



                                     -----------------------------------------



                                     -----------------------------------------



STATE OF ___________________________

COUNTY OF _________________________

         On the _______ day of  __________________,  19___ before me  personally
came,   _______________________________________   to  me   known   to   be   the
individual(s)  described  in and who  executed  the  foregoing  instrument,  and
acknowledged that he/she executed the same.

                                     ----------------------------------------
                                     Notary Public








                              CONTACT: Paul C. Desjourdy
                                       Exec. Vice President/CFO
                                       SYMBOLLON CORPORATION
FOR IMMEDIATE RELEASE                  (508) 443-0165


                         SYMBOLLON CORPORATION WITHDRAWS
                     510(K) PRE-MARKET NOTIFICATION FILING;
              WILL FOCUS ON OTHER POTENTIAL USES FOR ITS CHEMISTRY

SUDBURY,   MASSACHUSETTS,   December   10,   1996   --   Symbollon   Corporation
(NASDAQ:SYMBA,  SYMBW, SYMBZ) today announced that it has agreed to withdraw its
510(k)  pre-market  notification  filing to the FDA covering the Company's  high
level disinfectant formulation for the reprocessing of medical instruments.  The
Company is continuing to develop,  internally  and through  corporate  partners,
products in the infection prevention, dermatology and bioagricultural markets.

The  Company's  decision to  withdraw  the 510(k) was  prompted by two  concerns
raised  by the FDA  regarding  the  sporicidal  test  results  contained  in the
Company's 510(k) submission. These concerns focused on the test protocol used in
and the duration of time required to pass the AOAC  Sporicidal  Assay.  Dr. Jack
Kessler,  Chairman  of the Board of the  Company,  said with  regard to the test
protocol that "the Company's high level disinfectant  formulation is inactivated
by the silk carrier  required to be used under the current FDA guidelines in the
AOAC  Sporicidal  Assay.  Symbollon  used a Dacron carrier in order to produce a
more  scientifically  valid  result;  however,  the FDA has  indicated  that, at
present, such use of an alternative carrier is not acceptable.  The Company felt
its test results  demonstrated that its formulation was efficacious and safe for
the application."

Dr.  Kessler  further  stated that "based on the FDA's  present  position on the
sporicidal  test  requirements  and in  light  of the  Company's  other  product
development  opportunities,  which will not be impacted by the FDA position, the
Company currently does not plan to resubmit the 510(k) application.  The Company
intends to focus its resources on other areas of potential use for the Company's
chemistry,   in  the  infection  prevention,   dermatology  and  bioagricultural
markets."

                          ----------------------------

Symbollon  Corporation  is engaged in research and  development  of  proprietary
sterilants,  disinfectants,  antiseptics and sanitizers designed to kill a broad
spectrum  of  microorganisms  while  remaining  safe  to  both  people  and  the
environment.


                                      ####






                                CONTACT: Paul C. Desjourdy
                                         Exec. Vice President/CFO
                                         SYMBOLLON CORPORATION
FOR IMMEDIATE RELEASE                    (508) 443-0165


                         SYMBOLLON CORPORATION REQUESTS
                           CLASS B COMMON STOCKHOLDERS
                          TO CONVERT SUPERVOTING SHARES

SUDBURY,   MASSACHUSETTS,   December   13,   1996   --   Symbollon   Corporation
(NASDAQ:SYMBA, SYMBW, SYMBZ) today announced that the Company is  requesting its
Class B Common  Stockholders to voluntarily  convert their outstanding shares of
the Class B Common  Stock  (having 5 votes per  share)  into an equal  number of
shares of Class A Common  Stock  (having  one vote per  share),  pursuant to the
existing one-for-one  conversion rights of the Class B Common Stock. The purpose
of the request is to eliminate the supervoting  rights  attendant to the Class B
Common Stock.  The Class B shares  represent  77.6% of the votes  eligible to be
cast by Company's stockholders. If all of the Class B Common Stock is converted,
the converted Class B shares will represent 40.9% of the total voting power.

Dr. Jack  Kessler,  Chairman of the Board of the  Company,  said with regard the
Company's  request that "the Company  believes  that  conversion  of the Class B
Common Stock, thereby eliminating that class's supervoting power, should broaden
the  Company's  exposure in the  investment  community.  Members of the Board of
Directors who in the aggregate own, or control,  90.7% of the outstanding shares
of Class B Common Stock have indicated  their  intention to convert their shares
as part of this request.  If all of the Class B Common Stock is  converted,  the
voting  power  of the  Board  members  will be  reduced  from  71.5%  to  40.2%.
Ultimately,  by  converting  the Class B Common  Stock,  voting  control  of the
Company will be shifted from the Board of  Directors  to the  shareholders  as a
whole."

The Class B Common  Stockholders  will have until  January  15, 1997 to elect to
convert  pursuant  to the  Company's  request.  At least 98% of the  outstanding
shares  of Class B Common  Stock  must  elect to be  converted  in order for the
Company  to  process  the  conversions  pursuant  to its  request.  There can no
assurances that the Company will receive conversion  elections from the required
percentage of shares of Class B Common Stock.



                          ----------------------------

Symbollon  Corporation  is engaged in research and  development  of  proprietary
sterilants,  disinfectants,  antiseptics and sanitizers designed to kill a broad
spectrum  of  microorganisms  while  remaining  safe  to  both  people  and  the
environment.

                                      ####


<PAGE>





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission